Conservative management of stage T2 or T3a bladder cancer with deep transurethral resection followed by four cycles of chemotherapy


Uygur M., Yaman I., Altug U. , Erol D.

BRITISH JOURNAL OF UROLOGY, vol.78, no.2, pp.201-204, 1996 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 78 Issue: 2
  • Publication Date: 1996
  • Doi Number: 10.1046/j.1464-410x.1996.01099.x
  • Title of Journal : BRITISH JOURNAL OF UROLOGY
  • Page Numbers: pp.201-204

Abstract

Objective To evaluate the efficacy of the conservative management of stage T2 and T3a bladder cancer with deep (radical) transurethral resection (TUR) followed by four cycles of chemotherapy with methotrexate, vinblastine, epirubicin and cisplatin (MVEC) and its impact on bladder preservation and tumour recurrences.